• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因使用醋酸亮丙瑞林和醋酸戈舍瑞林治疗前列腺癌而导致的注射部位肉芽肿。

Injection-site granulomas resulting from the administration of both leuprorelin acetate and goserelin acetate for the treatment of prostatic cancer.

作者信息

Shiota Masaki, Tokuda Noriaki, Kanou Takehiro, Yamasaki Humio

机构信息

Department of Urology and Pathology, Saga Prefectural Hospital, Koseikan, Saga, Japan.

出版信息

J Nippon Med Sch. 2007 Aug;74(4):306-8. doi: 10.1272/jnms.74.306.

DOI:10.1272/jnms.74.306
PMID:17878701
Abstract

Although injection-site granulomas caused by leuprorelin acetate have been reported, there have been no reports of granulomas caused by both leuprorelin acetate and goserelin acetate. An 81-year-old man presented with subcutaneous nodules of the abdominal wall and upper arm, where 11.25 mg of leuprorelin acetate had been injected for the treatment of prostate cancer. Because of these nodules, treatment was changed to goserelin acetate. Nevertheless, he presented with another subcutaneous nodule at the injection site. Histological examination showed that these nodules consisted of numerous giant cells that were CD3-positive T lymphocytes and CD68-positive histiocytes associated with granulomatous changes. The granulomas had likely been caused by delayed-type hypersensitivity to leuprorelin acetate injection. The granuloma that formed after goserelin acetate injection might thus have developed owing to the immunogenicity of the previous leuprorelin acetate injections. The patient underwent surgical castration. The present case suggests that both leuprorelin acetate and goserelin acetate can cause injection-site disorders.

摘要

虽然已有醋酸亮丙瑞林引起注射部位肉芽肿的报道,但尚无醋酸亮丙瑞林和醋酸戈舍瑞林二者均引起肉芽肿的报道。一名81岁男性因前列腺癌接受治疗,在腹壁和上臂注射了11.25mg醋酸亮丙瑞林后出现皮下结节。由于这些结节,治疗改为醋酸戈舍瑞林。然而,他在注射部位又出现了一个皮下结节。组织学检查显示,这些结节由大量巨细胞组成,这些巨细胞为CD3阳性T淋巴细胞和CD68阳性组织细胞,并伴有肉芽肿性改变。这些肉芽肿可能是由对醋酸亮丙瑞林注射的迟发型超敏反应引起的。因此,醋酸戈舍瑞林注射后形成的肉芽肿可能是由于先前醋酸亮丙瑞林注射的免疫原性所致。该患者接受了手术去势。本病例提示醋酸亮丙瑞林和醋酸戈舍瑞林均可引起注射部位疾病。

相似文献

1
Injection-site granulomas resulting from the administration of both leuprorelin acetate and goserelin acetate for the treatment of prostatic cancer.因使用醋酸亮丙瑞林和醋酸戈舍瑞林治疗前列腺癌而导致的注射部位肉芽肿。
J Nippon Med Sch. 2007 Aug;74(4):306-8. doi: 10.1272/jnms.74.306.
2
[Surgical management of inflammatory granuloma which developed following subcutaneous injection of leuprorelin acetate: a case report].
Hinyokika Kiyo. 2005 Jul;51(7):487-9.
3
Leuprorelin acetate granulomas: case reports and review of the literature.醋酸亮丙瑞林肉芽肿:病例报告及文献综述
Br J Dermatol. 2005 May;152(5):1045-7. doi: 10.1111/j.1365-2133.2005.06341.x.
4
Injection-site granulomas due to the administration of leuprorelin acetate for the treatment of prostatic cancer.因使用醋酸亮丙瑞林治疗前列腺癌而导致的注射部位肉芽肿。
Fukuoka Igaku Zasshi. 2007 Jul;98(7):301-4.
5
[Cutaneous epithelioid granulomas caused by subcutaneous infusion of leuprorelin acetate: a case report].
Hinyokika Kiyo. 2004 Mar;50(3):199-202.
6
Granulomas induced by subcutaneous injection of leuprorelin acetate.皮下注射醋酸亮丙瑞林诱导的肉芽肿。
J Dermatol. 2006 Jan;33(1):43-5. doi: 10.1111/j.1346-8138.2006.00008.x.
7
[Investigation of incidence and risk factors of subcutaneous granulomas induced by injection of leuprorelin acetate].[醋酸亮丙瑞林注射所致皮下肉芽肿的发生率及危险因素调查]
Hinyokika Kiyo. 2015 Feb;61(2):55-9.
8
A morphological study of granulomas induced by subcutaneous injection of leuprorelin acetate.皮下注射醋酸亮丙瑞林诱导肉芽肿的形态学研究
J Cutan Pathol. 2009 Dec;36(12):1299-302. doi: 10.1111/j.1600-0560.2009.01270.x.
9
Incidence rate of injection-site granulomas resulting from the administration of luteinizing hormone-releasing hormone analogues for the treatment of prostatic cancer.用于治疗前列腺癌的促黄体生成激素释放激素类似物给药所致注射部位肉芽肿的发病率。
Yonsei Med J. 2007 Jun 30;48(3):421-4. doi: 10.3349/ymj.2007.48.3.421.
10
Randomised crossover trial to assess the tolerability of LHRH analogue administration.评估促黄体生成素释放激素类似物给药耐受性的随机交叉试验。
Prostate Cancer Prostatic Dis. 2003;6(2):187-9. doi: 10.1038/sj.pcan.4500625.

引用本文的文献

1
Novel insights into post-marketing AEs associated with leuprorelin: A comprehensive analysis utilizing the FAERS database.对亮丙瑞林相关上市后不良事件的新见解:利用FAERS数据库进行的综合分析。
Heliyon. 2024 Jul 21;10(15):e34969. doi: 10.1016/j.heliyon.2024.e34969. eCollection 2024 Aug 15.
2
Bilateral injection-site granuloma by subcutaneous administration of luteinizing hormone-releasing hormone analogue: a case report.皮下注射促黄体生成素释放激素类似物致双侧注射部位肉芽肿:一例报告
Cases J. 2009 Sep 15;2:8326. doi: 10.4076/1757-1626-2-8326.
3
NanoART, neuroAIDS and CNS drug delivery.
纳米医学、神经艾滋病与中枢神经系统药物递送
Nanomedicine (Lond). 2009 Jul;4(5):557-74. doi: 10.2217/nnm.09.38.